Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Neoplasm

Explore clinical trials studying Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.

112 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm trial results

Completed

Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms

NCT03072043

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

NCT01822509

Conditions
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

NCT04192916

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Mount Sinai New York New York, United States
  • Princess Margaret Cancer Centre Toronto Toronto, Canada
  • Centre Hospitalier Universitaire de Brest Brest, France
  • RWTH Aachen University Aachen, Germany
View all 18 locations
View Trial Details
Completed

Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT02029950

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Myelomonocytic Leukemia-2, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Completed

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00397813

Conditions
Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
Locations
  • LDS Hospital Salt Lake City, Utah, United States
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

NCT00723099

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details
Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

NCT02311569

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View Trial Details

Related conditions